- CDK4/6-Based Therapies in HR+ Breast Cancer: Optimizing Treatment Selection
- Sequencing Targeted Therapies in Advanced/ Metastatic HR+/HER2-Negative Breast Cancer
- Advancements in HER2+ BC
- Updates in Triple Negative Breast Cancer
- Live Q&A
BREAST CANCER
The Westin Galleria Dallas
13340 Dallas Pkwy, Dallas, TX 75240
United States
Thursday, November 12, 2026 | 6:00 PM-9:00 PM CST
Registration for this Summit is complimentary and includes dinner, drinks,
and entry into a raffle for a chance to win a gift of your choice.
IN PARTNERSHIP WITH
OVERVIEW
OncLive® State of the Science Summit® (SOSS) has been refreshed into a more interactive, discussion-based format designed for academic and community-based physicians and healthcare professionals. This dynamic Summit moves beyond traditional didactic presentations to a live, peer-to-peer panel discussion experience focused on how leading experts interpret emerging data and apply it in real-world cancer care. Attendees will gain practical, clinically relevant insights through active faculty dialogue, collaborative discussion, and real-time exchange of perspectives.
Registration for this Summit is complimentary and includes dinner, drinks, and entry into a raffle for a chance to win a gift of your choice.
DISCUSSION TOPICS INCLUDE:
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831